MedDataX Logo

Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function

NCT ID: NCT00881335

Last Updated: 2012-06-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices in elders of gerocomium.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Respiratory diseases are still increasing in the elderly population. The fluttering mucus clearance technique is expected to be a physical assisting therapy enhancing airway secretion clearance but needs more clinical randomized, controlled trial evidence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

geriatric pulmonary disease flutter sputum physical therapy techniques

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Group Type NO_INTERVENTION

No interventions assigned to this group

intervention

Intervention group were given flutter valve mucus clearance devices to do pulmonary function exercise

Group Type EXPERIMENTAL

flutter mucus clearance device

Intervention Type DEVICE

five minutes every sessions, three sessions per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

flutter mucus clearance device

five minutes every sessions, three sessions per day

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* available to perform the device, the elders in geracomium
* male and female
* aging 85 years or more

Exclusion Criteria

* not available to perform the procedure
* untreated pneumothorax
* diffusion interstitial lung disease
* acute coronary syndrome
* third stage hypertension
* advanced cancer
* severe heart, liver, renal, blood system and endocrine system dysfunction
* noninvasive mechanical ventilation
* active hemoptysis
Minimum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tongji University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhang Xiangyu

MD, director, professor, FCCM, FCCP.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhang Xiangyu, MD

Role: PRINCIPAL_INVESTIGATOR

Shanghai Tebth People's Hospital

References

Explore related publications, articles, or registry entries linked to this study.

Wang QX, Zhang XY, Li Q. Effects of a flutter mucus-clearance device on pulmonary function test results in healthy people 85 years and older in China. Respir Care. 2010 Nov;55(11):1449-52.

Reference Type DERIVED
PMID: 20979671 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHDC12007211-O

Identifier Type: -

Identifier Source: org_study_id